GILEAD SCIENCES, INC. - Common Stock (GILD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
GILD on Nasdaq
CUSIP
375558103
Type / Class
Equity / Common Stock
Shares outstanding
1.24B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.05B
Holdings value
$117B
% of all portfolios
0.052%
Grand Portfolio weight change
-0.004%
Number of holders
1983
Number of buys
963
Number of sells
-830
Average Value change %
0%
Average buys %
+0.006%
Average sells %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GILEAD SCIENCES, INC. - Common Stock (GILD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.2% $10.8B 102M BlackRock, Inc. Mar 31, 2025
Capital World Investors 4.3% $5.71B 53.8M Capital World Investors Mar 31, 2025

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.05B $117B -$2.27B $111.00 1,983
2025 Q2 1.07B $119B +$3.49B $110.87 1,999
2025 Q1 1.04B $117B -$1.85B $112.05 1,983
2024 Q4 1.06B $98B +$3.23B $92.37 1,848
2024 Q3 1.02B $85.7B -$936M $83.84 1,701
2024 Q2 1.03B $70.9B +$951M $68.61 1,650
2024 Q1 1.02B $74.8B -$1.78B $73.25 1,677
2023 Q4 1.04B $84.3B +$1.58B $81.01 1,740
2023 Q3 1.02B $76.6B -$1.21B $74.94 1,651
2023 Q2 1.04B $80.1B +$434M $77.07 1,670
2023 Q1 1.03B $85.4B +$629M $82.97 1,697
2022 Q4 1.03B $88.2B +$2.23B $85.85 1,730
2022 Q3 1B $61.7B +$664M $61.69 1,562
2022 Q2 990M $61.2B +$320M $61.81 1,580
2022 Q1 986M $58.6B -$959M $59.45 1,567
2021 Q4 1.01B $73.1B +$196M $72.61 1,662
2021 Q3 997M $69.6B +$698M $69.85 1,541
2021 Q2 987M $67.9B +$682M $68.86 1,524
2021 Q1 979M $63.2B +$778M $64.63 1,550
2020 Q4 970M $56.5B -$197M $58.26 1,542
2020 Q3 975M $61.5B -$1.23B $63.19 1,518
2020 Q2 989M $76.1B -$477M $76.94 1,616
2020 Q1 998M $74.6B -$1.15B $74.76 1,634
2019 Q4 1.01B $65.8B +$38.5M $64.98 1,543
2019 Q3 1.01B $64.2B -$199M $63.38 1,446
2019 Q2 1.02B $68.7B +$1.16B $67.56 1,469
2019 Q1 1.02B $66B -$253M $65.01 1,472
2018 Q4 1.02B $63.7B +$28.3M $62.55 1,475
2018 Q3 1.02B $78.9B +$2.22B $77.21 1,523
2018 Q2 993M $70.3B -$2.37B $70.84 1,521
2018 Q1 1.02B $77.2B +$355M $75.39 1,562
2017 Q4 1.02B $73.2B +$1.02B $71.64 1,577
2017 Q3 1B $81.4B +$2.31B $81.02 1,508
2017 Q2 978M $69.2B +$314M $70.78 1,521
2017 Q1 975M $66.2B +$5.36B $67.92 1,521
2016 Q4 991M $71B -$496M $71.61 1,569
2016 Q3 995M $78.6B -$3.55B $79.12 1,546
2016 Q2 1.04B $86.7B -$2.51B $83.42 1,587
2016 Q1 1.07B $98.1B -$6.51B $91.86 1,619
2015 Q4 1.14B $115B -$3.13B $101.19 1,620
2015 Q3 1.16B $114B -$3.24B $98.19 1,559
2015 Q2 1.17B $137B -$3.77B $117.08 1,551
2015 Q1 1.23B $121B -$2.16B $98.13 1,481
2014 Q4 1.26B $119B -$4.39B $94.26 1,426
2014 Q3 1.29B $138B -$8.23B $106.45 1,316
2014 Q2 1.38B $114B -$1.97B $82.91 1,266
2014 Q1 1.4B $99.4B -$665M $70.86 1,175